Amplification of a particular DNA sequence in Streptomyces ambofaciens RP181110 reversibly prevents spiramycin production. - Archive ouverte HAL Access content directly
Journal Articles Research in Microbiology Year : 1992

Amplification of a particular DNA sequence in Streptomyces ambofaciens RP181110 reversibly prevents spiramycin production.

, (1) , , ,
1
A Dary
  • Function : Author
N Girard
  • Function : Author
J M Simonet
  • Function : Author
B Decaris
  • Function : Author

Abstract

Streptomyces ambofaciens RP181110 produces the macrolide antibiotic spiramycin. After treatment with ethidium bromide, 7 strains presenting an amplified sequence of DNA (ADS) were found in its progeny. These ADS were localized within the same amplifiable region of the RP181110 genome. It has been established that these amplified strains were non-producers (Spi-) and that the loss of one particular ADS was correlated with restoration of spiramycin production. Genome rearrangements such as deletions were detected on the same side of the amplifiable region in both amplified and deamplified strains.
Not file

Dates and versions

hal-01625476 , version 1 (27-10-2017)

Identifiers

  • HAL Id : hal-01625476 , version 1
  • PUBMED : 1641517

Cite

A Dary, N Bourget, N Girard, J M Simonet, B Decaris. Amplification of a particular DNA sequence in Streptomyces ambofaciens RP181110 reversibly prevents spiramycin production.. Research in Microbiology, 1992, pp.99-112. ⟨hal-01625476⟩
23 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More